{"classes":[{"categories":[{"measurements":[{"comment":"The upper limit of the confidence interval cannot be estimated because several participants are still alive.","groupId":"OG000","lowerLimit":"9.7","upperLimit":"NA","value":"19.2"},{"groupId":"OG001","lowerLimit":"2.7","upperLimit":"13.2","value":"4.4"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"26"}],"units":"Participants"}],"description":"OS is defined as the time from the date of first treatment to the date of death and was measured by Kaplan-Meier analysis.","dispersionType":"95% Confidence Interval","groups":[{"description":"Participants with anal cancer, non-neuroendocrine cervical cancer, P16 positive (P16+) oropharyngeal cancers, and other rare HPV associated tumors (e.g., squamous cell rectal, vulvar, vaginal, penile cancer, neuroendocrine cervical) naïve to checkpoint inhibition treated with M7824 at a flat dose of 1,200 mg intravenous (IV) once every 2 weeks until confirmed progressive disease, death, unacceptable toxicity, or study withdrawal.","id":"OG000","title":"Participants Naïve to Checkpoint Inhibition - M7824 1,200 mg Intravenous Once Every 2 Weeks"},{"description":"Participants with human papillomavirus (HPV) associated cancers refractory to checkpoint inhibition treated with M7824 at a flat dose of 1,200 mg intravenous (IV) once every 2 weeks until confirmed progressive disease, death, unacceptable toxicity, or study withdrawal.","id":"OG001","title":"Participants Refractory to Checkpoint Inhibition - M7824 1,200 mg Intravenous Once Every 2 Weeks"}],"paramType":"MEDIAN","populationDescription":"1/30 participants was not evaluable in the naïve group because the patient was determined to be HPV negative, and 1/27 was not evaluable in the refractory group because one participant was a screen failure and was not treated.","reportingStatus":"POSTED","timeFrame":"Time from the date of first treatment to the date of death, up to 3 years.","title":"Overall Survival (OS)","type":"SECONDARY","unitOfMeasure":"Months"}